Pharmit-TOP >> Product Information >> A development concept of the antiHelicobacter pylori medicine
AntiHelicobacter pylori medicine
By discovery of the Helicobacter pylori, it was cleared there were most of the stomach and intestines disease such as chronic gastritis, a gastric ulcer, the stomach cancer for Helicobacter pylori. However, Copernican change happened for the diagnosis and treatment.
These stomach and intestines disease has been regarded as a multiple factor disease by various factors conventionally. Therefore medicines (H2 blocker and a proton pump inhibitor) which modified a gastric mucosa protecting agent and degree of the gastric acid have been developed as a symptomatic treatment. Therefore, the medicine which unfortunately can remove Helicobacter pylori with only one medicine is not yet developed by the present.
Now, infectee number of Helicobacter pylori exceeds 50% of the population universally. Then, it is doubted the infection many people of a patient appealing for epigastric region malaise in the outpatient of illness Clinic. We are concentrating on the development of the anti-Helicobacter Pylori medicine of the type to obstruct the persistent infection at the same time protecting the gastric mucosal cell by a method different from the approach of the past.
